Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vendor concentration, acquisition costs, and supply-chain swings make TD SYNNEX’s regulatory disclosures far from light reading. If you have ever opened a 10-K hoping to isolate cloud revenue or searched dozens of Form 4s for executive stock moves, you know the challenge of decoding this solutions aggregator’s complex numbers.
Stock Titan solves that problem. Our AI-powered summaries turn a 250-page TD SYNNEX annual report 10-K simplified into key takeaways, while real-time alerts surface every TD SYNNEX Form 4 insider transactions real-time. Want the next TD SYNNEX quarterly earnings report 10-Q filing? We post it seconds after EDGAR, then highlight inventory days, gross-margin shifts, and regional sales trends. Need a quick view of material developments? The platform tags each TD SYNNEX 8-K material events explained so you see the impact of new vendor agreements instantly. Even the TD SYNNEX proxy statement executive compensation is distilled, outlining option grants and performance metrics in plain English.
Use the page to:
- Track TD SYNNEX insider trading Form 4 transactions alongside AI-flagged buying patterns
- Compare segments through TD SYNNEX earnings report filing analysis
- Get context for capital raises with TD SYNNEX 8-K material events explained
Whether you are understanding TD SYNNEX SEC documents with AI for strategic planning or monitoring a sudden uptick in TD SYNNEX executive stock transactions Form 4, Stock Titan delivers every form—10-K, 10-Q, 8-K, Form 4, S-8, 424B, and more—complete, searchable, and always current. TD SYNNEX SEC filings explained simply means you spend less time scrolling and more time deciding.
TD SYNNEX (SNX) reported insider activity by its Chief Executive Officer and director on 10/15/2025. The filing lists a disposition coded “F” of 4,048 shares at $156.81 and an acquisition coded “A” of 22,957 shares at $0 under the 2020 Stock Incentive Plan. After these transactions, the reporting person directly owned 182,292 common shares.
The restricted stock award vests as to one-third of the shares on each of the first three anniversaries of the grant date.
TD SYNNEX (SNX) filed a Form 144 notice for a proposed sale of up to 76,848 common shares on the NYSE through Goldman Sachs & Co. LLC, with an approximate sale date of 10/16/2025. The filing lists an aggregate market value of $11,912,208.48 for the shares.
The seller acquired 20,000 shares as RSU compensation on 06/30/2020 from the issuer, and 56,848 shares via stock options granted on 10/05/2021, indicated as a cashless exercise/same-day sale. Shares outstanding were 81,437,855; this is a baseline figure, not the amount being offered.
TD SYNNEX (SNX) reported an insider transaction by its President, North America. On 10/10/2025, the officer sold 521 shares of common stock at $155.98 per share. Following the transaction, the reporting person beneficially owns 11,781 shares, held directly.
This filing is an administrative disclosure of insider activity and does not, by itself, indicate any change in company operations or strategy.
TD SYNNEX Corp filing a Form 144 notifies a proposed sale of 521 common shares held as restricted stock. The shares were acquired from the issuer on
TD SYNNEX Corp. director and officer Dennis Polk reported multiple transactions on
TD SYNNEX Corporation disclosed supplemental indentures and forms for two series of senior notes as part of an 8-K filing dated
Thompson Reyna, listed as President, North America and an officer of TD SYNNEX Corp (SNX), reported multiple dispositions of common stock on a Form 4. The filing shows a disposition of 58 shares on 10/07/2025 at a price of $158.65, and two additional dispositions on 10/08/2025 for 65 and 158 shares at a reported price of $0 for each line. The reported post-transaction beneficial ownership decreased from 12,525 shares to 12,302 shares following the transactions. The form includes an explanation stating: "Charitable donation of shares of common stock."
TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on
TD SYNNEX Corp (SNX) Form 144 reports a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC on
TD SYNNEX Corporation filed an 8-K reporting an Underwriting Agreement relating to the Notes dated